Oregon Health and Science University
Joseph Quinn
This is a research study investigating elevated homocysteine in the blood of patients with Parkinson's disease who are currently receiving treatment with levodopa. We are evaluating if elevated homocysteine can be corrected using open label B vitamin therapy, as well as the impact of homocysteine levels on cognitive function.
Parkinson&Amp;#39;s Disease
Folic Acid 1 MG
Vitamin B6 25 MG
Vitamin B12
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 150 participants |
| Masking : | NONE |
| Primary Purpose : | TREATMENT |
| Official Title : | Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease |
| Actual Study Start Date : | 2024-03-05 |
| Estimated Primary Completion Date : | 2025-12-31 |
| Estimated Study Completion Date : | 2025-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 40 Years to 90 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Oregon Health & Science University (OHSU)
Portland, Oregon, United States, 97239